Q1 2025 Earnings Call Transcript May 2, 2025 Jo Russell: Good morning, everyone, and welcome to conference call for our first ...

Q1 2025 Results Conference Call April 30, 2025 3:30 PM ETCompany ParticipantsJo Russell - Head-Investor RelationsDawn Allen - ...

A common cause of phlegm is something called a post-nasal drip. This sounds horrible ... Treatment is with a nose spray (eg Beconase or Flixonase) containing a very dilute dose of steroid (which ...

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility disorders.

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years. The Food and Drug ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...